Studieoverzicht

 
 
  2015-02 MonaLEEsa-3       Follow up       Advanced/metastatic       HER2- HR+       Postmenopausal  
  2015-01 Monarch-3       Follow up       Advanced/metastatic       HER2- HR+       Postmenopausal  
  2014-02 BRAVO       Follow up       Advanced/metastatic       HER2-, any HR       Both pre- and postmenopausal  
  2014-01 MONALEESA-2       Follow up       Advanced/metastatic       HER2- HR+       Postmenopausal  
  2013-06 Biomarker Study Everolimus       Follow up       Advanced/metastatic       HER2- HR+       Postmenopausal  
  2013-05 BELLE-3       Follow up       Advanced/metastatic       HER2- HR+       Postmenopausal  
  2013-03 PERNETTA       Follow up       Advanced/metastatic       HER2+, any HR       Both pre- and postmenopausal  
  2011-01 Abiraterone       Follow up       Advanced/metastatic       HER2- HR+       Postmenopausal